223 related articles for article (PubMed ID: 27404188)
1. Reaching High-Risk Patients for HIV Preexposure Prophylaxis.
Riddell J; Cohn JA
JAMA; 2016 Jul; 316(2):211-2. PubMed ID: 27404188
[No Abstract] [Full Text] [Related]
2. Optimizing Delivery of Preexposure Prophylaxis--The Next Frontier.
Landovitz RJ
JAMA Intern Med; 2016 Jan; 176(1):85-6. PubMed ID: 26571121
[No Abstract] [Full Text] [Related]
3. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
Liu AY; Cohen SE; Vittinghoff E; Anderson PL; Doblecki-Lewis S; Bacon O; Chege W; Postle BS; Matheson T; Amico KR; Liegler T; Rawlings MK; Trainor N; Blue RW; Estrada Y; Coleman ME; Cardenas G; Feaster DJ; Grant R; Philip SS; Elion R; Buchbinder S; Kolber MA
JAMA Intern Med; 2016 Jan; 176(1):75-84. PubMed ID: 26571482
[TBL] [Abstract][Full Text] [Related]
4. Audit of patient retention in pre-exposure prophylaxis (PrEP) services in an integrated sexual reproductive health service setting.
Cochrane E; Knapper C
Int J STD AIDS; 2019 Dec; 30(14):1432-1435. PubMed ID: 31795927
[No Abstract] [Full Text] [Related]
5. HIV Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex with Men in a Community-Based Sexual Health Clinic.
Hojilla JC; Vlahov D; Crouch PC; Dawson-Rose C; Freeborn K; Carrico A
AIDS Behav; 2018 Apr; 22(4):1096-1099. PubMed ID: 29243109
[TBL] [Abstract][Full Text] [Related]
6. Preexposure Prophylaxis Awareness and Use in a Population-Based Sample of Young Black Men Who Have Sex With Men.
Khanna AS; Michaels S; Skaathun B; Morgan E; Green K; Young L; Schneider JA;
JAMA Intern Med; 2016 Jan; 176(1):136-8. PubMed ID: 26571368
[No Abstract] [Full Text] [Related]
7. Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report.
Hoornenborg E; Prins M; Achterbergh RCA; Woittiez LR; Cornelissen M; Jurriaans S; Kootstra NA; Anderson PL; Reiss P; de Vries HJC; Prins JM; de Bree GJ;
Lancet HIV; 2017 Nov; 4(11):e522-e528. PubMed ID: 28919303
[TBL] [Abstract][Full Text] [Related]
8. Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.
Mugo PM; Sanders EJ; Mutua G; van der Elst E; Anzala O; Barin B; Bangsberg DR; Priddy FH; Haberer JE
AIDS Behav; 2015 May; 19(5):794-801. PubMed ID: 25432877
[TBL] [Abstract][Full Text] [Related]
9. Brief Report: Transgender Women and Preexposure Prophylaxis Care: High Preexposure Prophylaxis Adherence in a Real-World Health Care Setting in New York City.
Starbuck L; Golub SA; Klein A; Harris AB; Guerra A; Rincon C; Radix AE
J Acquir Immune Defic Syndr; 2022 May; 90(1):15-19. PubMed ID: 35013087
[TBL] [Abstract][Full Text] [Related]
10. ACP Journal Club. Preexposure tenofovir-emtricitabine reduced HIV infection in men who have unprotected anal sex with men.
Sacks HS
Ann Intern Med; 2016 Jan; 164(2):JC3. PubMed ID: 26784493
[No Abstract] [Full Text] [Related]
11. PURLs: On-demand pill protocol protects against HIV.
Justesen K; Prasad S
J Fam Pract; 2016 Aug; 65(8):556-8. PubMed ID: 27660840
[TBL] [Abstract][Full Text] [Related]
12. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
[TBL] [Abstract][Full Text] [Related]
13. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
[TBL] [Abstract][Full Text] [Related]
14. Risk perception in MSM taking prep: a survey.
Whitlock G; Boccino S; Kanagalinghan U; Nwokolo N
Sex Transm Infect; 2017 Aug; 93(5):325. PubMed ID: 28729517
[No Abstract] [Full Text] [Related]
15. Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.
Zablotska IB; Selvey C; Guy R; Price K; Holden J; Schmidt HM; McNulty A; Smith D; Jin F; Amin J; Cooper DA; Grulich AE;
BMC Public Health; 2018 Feb; 18(1):210. PubMed ID: 29394918
[TBL] [Abstract][Full Text] [Related]
16. Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women.
Sheth AN; Momplaisir F; Dumond JB
JAMA; 2024 Mar; 331(11):912-914. PubMed ID: 38427361
[No Abstract] [Full Text] [Related]
17. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
[TBL] [Abstract][Full Text] [Related]
18. Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study.
Grant RM; Mannheimer S; Hughes JP; Hirsch-Moverman Y; Loquere A; Chitwarakorn A; Curlin ME; Li M; Amico KR; Hendrix CW; Anderson PL; Dye BJ; Marzinke MA; Piwowar-Manning E; McKinstry L; Elharrar V; Stirratt M; Rooney JF; Eshleman SH; McNicholl JM; van Griensven F; Holtz TH
Clin Infect Dis; 2018 May; 66(11):1712-1721. PubMed ID: 29420695
[TBL] [Abstract][Full Text] [Related]
19. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
[TBL] [Abstract][Full Text] [Related]
20. Preexposure Prophylaxis with Tenofovir/Emtricitabine Prevents HIV Infection In Men who Have Unprotected Anal Intercourse.
Ebell MH
Am Fam Physician; 2016 Mar; 93(6):520. PubMed ID: 26977839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
